Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03267238 · ClinicalTrials.gov registry record · Early Phase 1
Fecal Microbial Transplantation in Patients With Crohn's Disease
A Early Phase 1 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT03267238: Completed Early Phase 1 study, sponsored by Stony Brook University.
NCT03267238 is a Early Phase 1 study that has completed, run by Stony Brook University. The registered enrollment target is 9 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03267238, a Early Phase 1 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Fecal Microbiota Transplantation will be offered to eligible Crohn's disease patient as Investigational New Drug treatment
Primary Outcome
Number of participants with treatment-related adverse events with grade greater than 2 within one year after FMT will be reported.
Interventions
- BIOLOGICAL Fecal Microbial Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2022-02-15 |
| Phase | Early Phase 1 |
What the finished NCT03267238 record still lists
NCT03267238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Fecal Microbial Transplantation is the first listed.
NCT03267238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03267238 about?
NCT03267238 is a clinical study titled "Fecal Microbial Transplantation in Patients With Crohn's Disease". Fecal Microbiota Transplantation will be offered to eligible Crohn's disease patient as Investigational New Drug treatment
What is the current status of trial NCT03267238?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2017-06-16. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT03267238?
The interventions under investigation include: Fecal Microbial Transplantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT03267238?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03267238's enrollment target sits among peer trials
9 1746th of 2000 higher than 219 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI